| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Monte Rosa Therapeutics, Inc. | 10%+ Owner | Common Stock | 7,692,298 | $146,153,662 | $19.00 | 28 Jun 2021 | Indirect |
| Savara Inc | 10%+ Owner | Common Stock | 24,471,264 | $108,897,125 | $4.45 | 17 Jul 2023 | Indirect |
| Korro Bio, Inc. | 10%+ Owner | Common Stock | 1,090,793 | $61,084,408 | $56.00 | 22 Apr 2024 | Indirect |
| MBX Biosciences, Inc. | 10%+ Owner | Common Stock | 3,614,486 | $38,638,855 | $10.69 | 16 Sep 2024 | Indirect |
| Trevi Therapeutics, Inc. | 10%+ Owner | Pre-Funded Warrants | 3,000,000 | $5,697,000 | $1.90 | 11 Apr 2022 | Indirect |
| Trevi Therapeutics, Inc. | 10%+ Owner | Common Stock | 948,948 | $1,916,875 | $2.02 | 11 Apr 2022 | Indirect |
| Metacrine, Inc. | 10%+ Owner | Common Stock | 2,563,257 | $1,204,731 | $0.4700 | 22 Dec 2021 | Indirect |
| Mirum Pharmaceuticals, Inc. | 10%+ Owner | Common Stock | 11,348 | $318,142 | $28.04 | 13 Jun 2023 | Indirect |
| IonQ, Inc. | 10%+ Owner | Common Stock | 1,047 | $13,834 | $13.21 | 16 Nov 2022 | Indirect |
| Mirum Pharmaceuticals, Inc. | 10%+ Owner | Common Stock | 384 | $10,765 | $28.04 | 13 Jun 2023 | Direct |
| AVEO PHARMACEUTICALS, INC. | 10%+ Owner | Common Stock | 354 | $5,310 | $15.00 | 19 Oct 2022 | Indirect |
| Desktop Metal, Inc. | 10%+ Owner | Class A Common Stock | 806 | $591 | $0.7332 | 08 Jun 2021 | Indirect |
| NeueHealth, Inc. | Director, 10%+ Owner | Common Stock | 0 | $0 | $6.84 | 02 Oct 2025 | Indirect |
| Trevi Therapeutics, Inc. | 10%+ Owner | 3.5-Year Common Stock Warrant | 1,851,852 | 18 Oct 2021 | Indirect | ||
| Trevi Therapeutics, Inc. | 10%+ Owner | 7-Year Common Stock Warrant | 1,851,852 | 18 Oct 2021 | Indirect | ||
| Akouos, Inc. | 10%+ Owner | Common Stock | 0 | $12.50 | 30 Nov 2022 | Indirect | |
| Arcellx, Inc. | 10%+ Owner | Common Stock | 0 | $55.27 | 21 Dec 2022 | Indirect | |
| Casper Sleep Inc. | Director, 10%+ Owner | Common Stock | 0 | $6.90 | 25 Jan 2022 | Direct | |
| Casper Sleep Inc. | Director, 10%+ Owner | Common Stock | 0 | $6.90 | 25 Jan 2022 | Indirect | |
| Eargo, Inc. | 10%+ Owner | Common Stock | 0 | $2.59 | 24 May 2021 | Indirect | |
| GENOCEA BIOSCIENCES, INC. | 10%+ Owner | Common Stock | 0 | $1.25 | 25 May 2022 | Indirect | |
| MBX Biosciences, Inc. | 10%+ Owner | Series A Convertible Preferred Stock | 0 | 16 Sep 2024 | Indirect | ||
| MBX Biosciences, Inc. | 10%+ Owner | Series B Convertible Preferred Stock | 0 | 16 Sep 2024 | Indirect | ||
| Monte Rosa Therapeutics, Inc. | 10%+ Owner | Series A-2 convertible preferred stock | 0 | 28 Jun 2021 | Indirect | ||
| Monte Rosa Therapeutics, Inc. | 10%+ Owner | Series B convertible preferred stock | 0 | $2.00 | 28 Jun 2021 | Indirect | |
| Monte Rosa Therapeutics, Inc. | 10%+ Owner | Series C convertible preferred Stock | 0 | $2.96 | 28 Jun 2021 | Indirect | |
| NeueHealth, Inc. | Director, 10%+ Owner | Series A Convertible Perpetual Preferred Stock | 0 | 02 Oct 2025 | Indirect | ||
| NeueHealth, Inc. | Director, 10%+ Owner | Series B Convertible Perpetual Preferred Stock | 0 | 02 Oct 2025 | Indirect | ||
| NeueHealth, Inc. | Director, 10%+ Owner | Warrant (Right to Buy) | 0 | 02 Oct 2025 | Indirect | ||
| Robinhood Markets, Inc. | Director | Class A Common Stock | 0 | $12.28 | 03 May 2022 | Indirect | |
| Robinhood Markets, Inc. | Director | Common Stock | 0 | $34.32 | 02 Aug 2021 | Indirect | |
| Robinhood Markets, Inc. | Director | Series B Redeemable Convertible Preferred Stock | 0 | 02 Aug 2021 | Indirect | ||
| Robinhood Markets, Inc. | Director | Series C Redeemable Convertible Preferred Stock | 0 | 02 Aug 2021 | Indirect | ||
| Robinhood Markets, Inc. | Director | Series D Redeemable Convertible Preferred Stock | 0 | 02 Aug 2021 | Indirect | ||
| Robinhood Markets, Inc. | Director | Series E Redeemable Convertible Preferred Stock | 0 | 02 Aug 2021 | Indirect | ||
| Robinhood Markets, Inc. | Director | Series F Redeemable Convertible Preferred Stock | 0 | 02 Aug 2021 | Indirect | ||
| Robinhood Markets, Inc. | Director | Tranche I Convertible Promissory Note | 0 | 02 Aug 2021 | Indirect |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| NEUE | NeueHealth, Inc. | 02 Oct 2025 | 40 | +$19.5 | 4 | Director, 10%+ Owner | 06 Oct 2025, 17:53 |
| NEUE | NeueHealth, Inc. | 01 Oct 2024 | 4 | $0 | 4 | 10%+ Owner | 03 Oct 2024, 18:22 |
| MBX | MBX Biosciences, Inc. | 16 Sep 2024 | 5 | +$8,000,000 | 4 | 10%+ Owner | 17 Sep 2024, 20:21 |
| MBX | MBX Biosciences, Inc. | 12 Sep 2024 | 0 | $0 | 3 | 10%+ Owner | 12 Sep 2024, 19:27 |
| KRRO | Korro Bio, Inc. | 22 Apr 2024 | 1 | +$999,992 | 4 | 10%+ Owner | 24 Apr 2024, 17:00 |
| NEUE | NeueHealth, Inc. | 08 Apr 2024 | 4 | $0 | 4 | 10%+ Owner | 10 Apr 2024, 19:14 |
| NEUE | Bright Health Group Inc. | 19 Dec 2023 | 1 | $0 | 4 | 10%+ Owner | 21 Dec 2023, 16:58 |
| KRRO | Korro Bio, Inc. | 03 Nov 2023 | 0 | $0 | 3 | 10%+ Owner | 07 Nov 2023, 21:28 |
| NEUE | Bright Health Group Inc. | 31 Oct 2023 | 1 | $0 | 4 | 10%+ Owner | 02 Nov 2023, 18:40 |
| NEUE | Bright Health Group Inc. | 15 Sep 2023 | 1 | $0 | 4 | 10%+ Owner | 19 Sep 2023, 19:22 |
| NEUE | Bright Health Group Inc. | 11 Aug 2023 | 1 | $0 | 4 | 10%+ Owner | 15 Aug 2023, 22:53 |
| SVRA | Savara Inc | 17 Jul 2023 | 1 | +$999,999 | 4 | 10%+ Owner | 19 Jul 2023, 19:08 |
| MIRM | Mirum Pharmaceuticals, Inc. | 13 Jun 2023 | 5 | $0 | 4 | 10%+ Owner | 15 Jun 2023, 16:31 |
| ACLX | Arcellx, Inc. | 20 Dec 2022 | 5 | +$5,502 | 4 | 10%+ Owner | 22 Dec 2022, 17:37 |
| /report/000120919122059452-florence-anthony-a-jr-2022-11-30 | Akouos, Inc. | 30 Nov 2022 | 1 | $0 | 4 | 10%+ Owner | 02 Dec 2022, 16:06 |
| IONQ | IonQ, Inc. | 16 Nov 2022 | 4 | $0 | 4 | 10%+ Owner | 18 Nov 2022, 16:08 |
| /report/000120919122054288-florence-anthony-a-jr-2022-10-19 | AVEO PHARMACEUTICALS, INC. | 19 Oct 2022 | 6 | $0 | 4 | 10%+ Owner | 21 Oct 2022, 16:47 |
| NEUE | Bright Health Group Inc. | 17 Oct 2022 | 2 | +$137,700,000 | 4 | 10%+ Owner | 19 Oct 2022, 19:55 |
| /report/000120919122032323-florence-anthony-a-jr-2022-05-24 | GENOCEA BIOSCIENCES, INC. | 24 May 2022 | 2 | -$750,662 | 4 | 10%+ Owner | 26 May 2022, 18:23 |
| HOOD | Robinhood Markets, Inc. | 02 May 2022 | 8 | -$19,640 | 4 | Director | 04 May 2022, 19:42 |
| TRVI | Trevi Therapeutics, Inc. | 11 Apr 2022 | 3 | +$12,499,999 | 4 | 10%+ Owner | 13 Apr 2022, 17:18 |
| HOOD | Robinhood Markets, Inc. | 28 Jan 2022 | 8 | -$29,598 | 4 | Director | 01 Feb 2022, 18:19 |
| /report/000120919122005110-florence-anthony-a-jr-2022-01-25 | Casper Sleep Inc. | 25 Jan 2022 | 2 | -$43,165,682 | 4 | Director, 10%+ Owner | 26 Jan 2022, 16:58 |
| NEUE | Bright Health Group Inc. | 03 Jan 2022 | 2 | +$200,000,000 | 4 | 10%+ Owner | 05 Jan 2022, 16:49 |
| /report/000120919121071269-florence-anthony-a-jr-2021-12-10 | Metacrine, Inc. | 10 Dec 2021 | 3 | -$494,483 | 4 | 10%+ Owner | 27 Dec 2021, 15:43 |
| HOOD | Robinhood Markets, Inc. | 10 Nov 2021 | 4 | $0 | 4 | Director | 12 Nov 2021, 15:38 |
| HOOD | Robinhood Markets, Inc. | 27 Oct 2021 | 4 | $0 | 4 | Director, 10%+ Owner | 29 Oct 2021, 17:13 |
| TRVI | Trevi Therapeutics, Inc. | 18 Oct 2021 | 3 | $0 | 4 | 10%+ Owner | 19 Oct 2021, 21:13 |
| HOOD | Robinhood Markets, Inc. | 02 Aug 2021 | 20 | +$77,118,720 | 4 | Director, 10%+ Owner | 03 Aug 2021, 17:49 |
| HOOD | Robinhood Markets, Inc. | 29 Jul 2021 | 0 | $0 | 3 | Director, 10%+ Owner | 29 Jul 2021, 17:51 |
| NEUE | Bright Health Group Inc. | 28 Jun 2021 | 22 | +$34,999,992 | 4 | 10%+ Owner | 30 Jun 2021, 21:30 |
| GLUE | Monte Rosa Therapeutics, Inc. | 28 Jun 2021 | 7 | +$19,950,000 | 4 | 10%+ Owner | 30 Jun 2021, 18:02 |
| NEUE | Bright Health Group Inc. | 24 Jun 2021 | 0 | $0 | 3 | 10%+ Owner | 24 Jun 2021, 21:26 |
| GLUE | Monte Rosa Therapeutics, Inc. | 23 Jun 2021 | 0 | $0 | 3 | 10%+ Owner | 23 Jun 2021, 21:07 |
| /report/000120919121040330-florence-anthony-a-jr-2021-06-10 | Casper Sleep Inc. | 10 Jun 2021 | 1 | $0 | 4 | Director, 10%+ Owner | 14 Jun 2021, 18:22 |
| DM | Desktop Metal, Inc. | 08 Jun 2021 | 4 | $0 | 4 | 10%+ Owner | 10 Jun 2021, 16:39 |
| /report/000120919121035937-florence-anthony-a-jr-2021-05-24 | Eargo, Inc. | 24 May 2021 | 3 | $0 | 4 | 10%+ Owner | 26 May 2021, 16:36 |